Profil
Robin G.
Taylor is currently Chief Commercial Officer at Agenus, Inc. since 2023.
Formerly, Dr. Taylor was Chief Commercial Officer at Seagen, Inc. from 2019 to 2020 and Head-Immuno-Oncology Franchise at AstraZeneca PLC from 2018 to 2019.
Education includes an undergraduate degree from the University of British Columbia, a doctorate from the University of Toronto, and an MBA from the University of California, Berkeley.
Aktiva positioner av Robin Taylor
| Företag | Position | Start |
|---|---|---|
| AGENUS INC. | Företagsledare/Principal | 2023-07-20 |
Tidigare kända positioner av Robin Taylor
| Företag | Position | Slut |
|---|---|---|
| SEAGEN INC. | Företagsledare/Principal | 2020-02-01 |
| ASTRAZENECA PLC | Företagsledare/Principal | 2019-04-01 |
Robin Taylors utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















